We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+5.55%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$5.86B
AUM Growth
+$813M
(+16%)
Cap. Flow
+$544M
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
50.44%
Holding
3,726
New
379
Increased
1,205
Reduced
834
Closed
278
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$68.1M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$66.4M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$59M |
| 4 |
Vanguard Mid-Cap ETF
VO
|
+$49.9M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$26.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$77.7M |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$5.23M |
| 3 |
WisdomTree Emerging Markets Local Debt Fund
ELD
|
+$3.78M |
| 4 |
Invesco Preferred ETF
PGX
|
+$3.67M |
| 5 |
Nuveen Municipal High Income Opportunity Fund
NMZ
|
+$2.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 6.93% |
| 2 | Financials | 4.55% |
| 3 | Technology | 3.35% |
| 4 | Industrials | 2.51% |
| 5 | Healthcare | 2.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
McCormick & Company Non-Voting
MKC
$13.4B
| $1.01M | 0.02% |
29,180
-356
| -1% | -$12.1K |
|
302
Petrobras
PBR
$121B
| $1.01M | 0.02% |
72,995
+66,821
| +1,082% | +$1.04M |
|
303
Valero Energy
VLO
$89.8B
| $997K | 0.02% |
19,783
+678
| +4% | +$28.6K |
|
|
SDRL
304
DELISTED
Seadrill Limited Common Stock
SDRL
| $997K | 0.02% |
91
-6
| -6% | -$70.8K |
|
305
Teva Pharmaceuticals
TEVA
$35.9B
| $996K | 0.02% |
24,842
-5,176
| -17% | -$204K |
|
306
NVR
NVR
$17.2B
| $990K | 0.02% |
965
-1,118
| -54% | -$1.06M |
|
|
TIF
307
DELISTED
Tiffany & Co.
TIF
| $989K | 0.02% |
10,664
+10,228
| +2,346% | +$850K |
|
|
RTN
308
DELISTED
Raytheon Company
RTN
| $977K | 0.02% |
10,777
+627
| +6% | +$52.3K |
|
|
STJ
309
DELISTED
St Jude Medical
STJ
| $977K | 0.02% |
15,763
+86
| +0.5% | +$4.98K |
|
310
iShares S&P 500 Growth ETF
IVW
$72.5B
| $973K | 0.02% |
39,416
-3,052
| -7% | -$71.9K |
|
311
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
| $971K | 0.02% |
11,507
-3,021
| -21% | -$255K |
|
312
Vanguard Mid-Cap Value ETF
VOE
$23.7B
| $971K | 0.02% |
12,167
+504
| +4% | +$38.9K |
|
313
Ross Stores
ROST
$76.6B
| $968K | 0.02% |
25,844
+708
| +3% | +$26.6K |
|
314
iShares Silver Trust
SLV
$28.1B
| $967K | 0.02% |
51,664
-7,900
| -13% | -$158K |
|
|
XCO
315
DELISTED
Exco Resources
XCO
| $966K | 0.02% |
12,133
+11,982
| +7,935% | +$1.02M |
|
|
PBCT
316
DELISTED
People's United Financial Inc
PBCT
| $961K | 0.02% |
63,531
-540
| -0.8% | -$7.94K |
|
317
Ralph Lauren
RL
$22.2B
| $960K | 0.02% |
5,435
-110
| -2% | -$18.7K |
|
|
COV
318
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $958K | 0.02% |
14,064
+2,161
| +18% | +$141K |
|
319
Zimmer Biomet
ZBH
$17.7B
| $955K | 0.02% |
10,550
+1,785
| +20% | +$154K |
|
|
CHK
320
DELISTED
Chesapeake Energy Corporation
CHK
| $954K | 0.02% |
186
+85
| +84% | +$432K |
|
321
HCA Healthcare
HCA
$84.8B
| $950K | 0.02% |
19,920
+9,010
| +83% | +$416K |
|
|
DFS
322
DELISTED
Discover Financial Services
DFS
| $948K | 0.02% |
16,936
+2,226
| +15% | +$117K |
|
323
APA Corp
APA
$12.8B
| $943K | 0.02% |
10,968
+801
| +8% | +$71.3K |
|
324
Adobe
ADBE
$89.5B
| $942K | 0.02% |
15,738
+103
| +0.7% | +$5.69K |
|
325
Vanguard Small-Cap Growth ETF
VBK
$23.2B
| $942K | 0.02% |
7,705
-349
| -4% | -$41.2K |
|
Similar funds
Creative Planning's Q4 2013 Portfolio in Review
As of Q4 2013, Creative Planning held 3,726 positions worth $5.86B, up 16% from $5.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Creative Planning deployed $544M of net new capital in Q4 2013, opening 379 new positions and adding to 1,205 existing holdings. Its largest new stake was Allergan plc: 7,924 shares worth $1.33M.
By sector, the portfolio is most concentrated in Energy at 6.9% of assets, up from 6.3% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $77.7M trimmed.
- Creative Planning's largest Q4 2013 buy was Allergan plc: 7,924 shares worth $1.33M.
- Creative Planning added most to Vanguard FTSE Developed Markets ETF in Q4 2013, an estimated $68.1M increase.
- Creative Planning's biggest Q4 2013 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $77.7M.
- Creative Planning fully exited Pioneer Municipal High Income Advantage Fund in Q4 2013, selling an estimated $1.95M.
- Creative Planning's ten largest holdings make up 50% of its $5.86B portfolio in Q4 2013.
- Creative Planning opened 379 new positions and closed 278 in Q4 2013.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $5.86B.
Based on Creative Planning's 13F filing for Q4 2013, filed 6 Jan 2014.